Related Experiment Video
Updated: Oct 17, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
In Vitro Activity of Omadacycline and Five Comparators against Contemporary Ribotypes of Clostridioides difficile in
Angela Camporeale1, Chaitanya Tellapragada1, Jelena Kornijenko1
1Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutegrid.4714.6t, Stockholm, Sweden.
Abstract:
Clostridioides difficile infection represents a growing clinical challenge. The new compound omadacycline is a potential treatment alternative, as many antibiotics have limited activity or are rarely used due to costs and side effects. The activity of omadacycline and five comparators was assessed with agar dilution on a 2015-to-2018 collection of 65 C. difficile isolates from Sweden. Omadacycline demonstrated in vitro activity against the contemporary ribotypes of C. difficile, and further clinical investigation is needed. IMPORTANCE Evaluating the activity of novel antimicrobials like omadacycline is of great interest, as a reliable and efficient antimicrobial treatment for Clostridioides difficile infections is in demand.
Insights
Omadacycline shows promising in vitro activity against Clostridioides difficile, a growing cause of infection. Further clinical studies are needed to evaluate this novel antibiotic as a potential treatment option.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Clostridioides difficile infection (CDI) presents a significant and increasing clinical challenge.
- Existing antibiotic treatments for CDI have limitations, including reduced efficacy and adverse side effects.
- There is a critical need for novel and effective antimicrobial agents to combat CDI.
Purpose of the Study:
- To evaluate the in vitro activity of omadacycline against contemporary isolates of Clostridioides difficile.
- To compare the efficacy of omadacycline with other antibiotics against C. difficile.
Main Methods:
- Agar dilution method was employed to assess antimicrobial activity.
- A collection of 65 C. difficile isolates from Sweden (2015-2018) was used for testing.
- Omadacycline and five comparator agents were tested against the isolates.
Main Results:
- Omadacycline demonstrated in vitro activity against the tested Clostridioides difficile isolates.
- The activity was observed across contemporary ribotypes of C. difficile.
- Specific data on comparator agent activity is implied but not detailed in the abstract.
Conclusions:
- Omadacycline exhibits promising in vitro activity against Clostridioides difficile.
- Further clinical investigation is warranted to establish omadacycline's therapeutic potential for CDI.
- The development of new treatments for CDI remains a priority.
Related Concept Videos
Antimicrobial Effectiveness
Antibiotic Selection
Development of Antibiotic Resistance

